Refresh

Solara Active Pharma Sciences Ltd. - Research Center

541540 SOLARA Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

1,443.81 1,268.34 1,616.88 1,321.75 1,367.26
Expenses

Material consumed

813.22 681.32 753.84 623.62 723.76

Manufacturing expenses

107.95 92.12 84.06 76.22 72.64

Personnel expenses

228.05 234.20 227.63 202.24 179.92

Selling expenses

- - - - -

Adminstrative expenses

160.55 180.35 166.02 163.14 164.88

Expenses capitalised

- - - - -

Cost of sales

1,309.77 1,187.99 1,231.55 1,065.22 1,141.20

Operating profit

134.04 80.35 385.33 256.53 226.06

Other recurring income

22.14 18.76 28.41 27.51 6.79

Adjusted PBDIT

156.18 99.11 413.74 284.04 232.85

Financial expenses

90.06 75.27 84.47 77.88 82.42

Depreciation

110.90 112.01 108.31 93.67 78.73

Other write offs

- - - - -

Adjusted PBT

-44.78 -88.17 220.96 112.49 71.71

Tax charges

-22.57 -33.10 - - 2.02

Adjusted PAT

-22.21 -55.07 - - 69.69

Non recurring items

-1.76 -1.48 -2.53 -3.29 -9.02

Other non cash adjustments

- - - - -

Reported net profit

-23.97 -56.55 218.43 109.20 60.67

Earnigs before appropriation

250.04 284.79 361.08 158.87 52.97

Equity dividend

- 10.78 19.74 15.66 -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

250.04 274.01 341.34 143.21 52.97
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com